Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Inositol
Selected research topic
Men's health
Changes were observed before and after use, but they cannot be attributed to this ingredient.
Findings from a combination study cannot be attributed to this ingredient alone.
Some publications still need interpretation checks and are kept separate from the findings below.
Some findings concern patients or people with a deficiency.
- Publications for this topic
- 7
- Human comparison publications
- 0
- Publications needing review
- 5
Findings in the studies
sperm motility
Publications linked to this measurement: 1
Other human research, including observational studies and reviews
- A change was reported before and after use. Its cause cannot be isolated.
Several ingredients were tested together, so this ingredient’s individual effect is unknown.
Patient group · Combination study · After 3 months of treatmentMeasurement and study conditions
- Study type
- Clinical trial
- Study population
- Human participants · Patient group
- Ingredients tested
- Ingredient combination
- How results were compared
- Changes within the same group were compared. · Study comparison: Within-person pre/post report; no control group stated; 14 patients had no benefit and 2 worsened
- Measurement time
- After 3 months of treatment
testosterone
Publications linked to this measurement: 1
Other human research, including observational studies and reviews
- A change was reported before and after use. Its cause cannot be isolated.Patient group · Single ingredient · 30 days
Measurement and study conditions
- Study type
- Clinical trial
- Study population
- Human participants · Patient group
- Ingredients tested
- Single ingredient
- How results were compared
- Changes within the same group were compared. · Study comparison: within-person baseline to 30-day DCI treatment change; no control group
- Measurement time
- 30 days
This result is held for interpretation. That does not mean research found no effect.
Outcome groups needing additional review (4)
- LH · Distinct papers needing additional review: 1Evidence criteria check: 1
- pregnancy · Distinct papers needing additional review: 1Applicability check needed: 1
- serum levels of testosterone · Distinct papers needing additional review: 1Evidence criteria check: 1
- serum testosterone levels · Distinct papers needing additional review: 1Evidence criteria check: 1
One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.
Representative outcome and study details
Human studies reported a within-group change in sperm motility.
combination-ingredient studies · Individual ingredient effects cannot be separated · Human studies · Includes patient groups · within-group comparison
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
- Combination, formula, or class studies do not isolate this ingredient or establish synergy.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: B
The 54.3 evidence score includes 0 independent human studies and 0 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 101
Papers linked to this topic 7 · distinct papers 7 · comparison findings need further review · papers needing additional review 5
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- LH: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- pregnancy: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- serum levels of testosterone: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- serum testosterone levels: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- sperm motility: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- testosterone: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
What the research found
sperm motility
A change was reported before and after use. Its cause cannot be isolated.
Other evidence · Ingredient combination · Patient group
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
Within-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
testosterone
A change was reported before and after use. Its cause cannot be isolated.
Other evidence · Single ingredient · Patient group
Within-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
LH
The study needs further checking before its result can be interpreted.
Other evidence · Ingredient combination · Patient group
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
pregnancy
The study needs further checking before its result can be interpreted.
Other evidence · Single ingredient · Patient group
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
serum levels of testosterone
The study needs further checking before its result can be interpreted.
Other evidence · Single ingredient · General population
Within-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
serum testosterone levels
The study needs further checking before its result can be interpreted.
Other evidence · Single ingredient · Patient group
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Unspecified measured outcome
The study needs further checking before its result can be interpreted.
Other evidence · Unknown intervention · Unspecified population
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No reviewed caution rules are available yet. Reported caution findings are shown below.
Review 1 combination findings and 0 findings that outperformed an ingredient alone.
Findings to review with care
Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.
Side effects reported with this ingredient alone
Symptoms or adverse events reported in studies without another active ingredient.
serum testosterone levels1 papers
In young adult female mice, DCIns at 5 mg/day increased serum testosterone and altered ovarian histology, while 10–20 mg/day reduced testosterone and caused age‑like ovarian lesions, indicating potential toxicity at higher doses.Animal studies · Animal studyReported improvements with combinations
Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.
Combinations with reported improvement
The combination showed improvement, but each ingredient's contribution is unclear.
SeleniumCombined administration of myo-inositol and selenium significantly decreased TSH, TPOAb, and TgAb levels and enhanced thyroid hormones compared to baseline.